High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 515-521

  Shahmoradi, Sajad ^a   Yahyapour, Yousef ^b   Mahmoodi, Mahmood ^a   Alavian, Seyed Moayed ^c   Fazeli, Zeinab ^a   Jazayeri, Seyed Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Escape mutants; HBsAg mutant assays; HBsAg vaccine; Occult hepatitis B infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HYPER HEP B; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CHILD; DNA SEQUENCE; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOPROPHYLAXIS; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MOTHER; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SEROLOGY; VACCINATION; VIRUS LOAD;

CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84865126109     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.021     Document Type: Article

References (57)

1. M.P. Cooreman, M.H. van Roosmalen, R. te Morsche, C.M. Sunnen, E.M. de Ven, and J.B. Jansen Characterization of the reactivity pattern of murine monoclonal antibodies against wild type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations Hepatology 30 1999 1287 1292 (Pubitemid 29510868)
2. W.F. Carman, A.R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, and E. Tanzi Vaccine-induced escape mutant of hepatitis B virus Lancet 336 1990 325 329 (Pubitemid 20264145)
3. A.J. Zuckerman Effect of hepatitis B virus mutants on efficacy of vaccination Lancet 355 2000 1382 1384 (Pubitemid 30215956)
4. S. Ijaz, F. Torre, R.S. Tedder, R. Williams, and N.V. Naoumov Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients J Med Virol 63 2001 210 216 (Pubitemid 32116475)
5. K. Yamamoto, M. Horikita, F. Tsuda, K. Itoh, Y. Akahane, and S. Yotsumoto Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen J Virol 68 1994 2671 2676 (Pubitemid 24091946)
6. W.F. Carman, J. Korula, L. Wallace, R. MacPhee, L. Mimms, and R. Decker Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA Lancet 345 1995 1406 1407
7. J.H. Ireland, B. O'Donnell, A.A. Basuni, J.D. Kean, L.A. Wallace, and G.K. Lau Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays Hepatology 31 2000 1176 1182 (Pubitemid 30233244)
8. B. Weber Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene J Med Virol 78 Suppl. 1 2006 S59 S65
9. F.B. Hollinger, and B. Hepatitis Virus genetic diversity and its impact on diagnostic assays J Viral Hepat 14 Suppl. 1 2007 11 15 (Pubitemid 47624107)
10. W.F. Carman The clinical significance of surface antigen variants of hepatitis B virus J Viral Hepat 4 Suppl. 1 1997 11 20
11. U. Protzer-Knolle, U. Naumann, R. Bartenschlager, T. Berg, U. Hopf, and K.H. Meyer zum Buschenfelde Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 27 1998 254 263
12. H. Okamoto, K. Yano, Y. Nozaki, A. Matsui, H. Miyazaki, and K. Yamamoto Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine Pediatr Res 32 1992 264 268
13. C. Brechot, V. Thiers, D. Kremsdorf, B. Nalpas, S. Pol, and P. Paterlini-Brechot Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 34 2001 194 203 (Pubitemid 32591500)
14. F.B. Hollinger, P. Habibollahi, A. Daneshmand, and S.M. Alavian Occult hepatitis B infection in chronic hemodialysis patients: current concepts and strategy Hepat Mon 10 2010 199 204
15. E. Giannini, P. Ceppa, F. Botta, A. Fasoli, P. Romagnoli, and F. Ansaldi Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients Liver Int 23 2003 12 18 (Pubitemid 37265769)
16. I. Cacciola, T. Pollicino, G. Squadrito, G. Cerenzia, M.E. Orlando, and G. Raimondo Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Engl J Med 341 1999 22 26 (Pubitemid 29293716)
17. K.Q. Hu Occult hepatitis B virus infection and its clinical implications J Viral Hepat 9 2002 243 257
18. P. Fabris, D. Brown, G. Tositti, L. Bozzola, M.T. Giordani, and P. Bevilacqua Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C J Clin Virol 29 2004 160 166 (Pubitemid 38201461)
19. T. Pollicino, G. Squadrito, G. Cerenzia, I. Cacciola, G. Raffa, and A. Craxi Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 2004 102 110 (Pubitemid 38040728)
20. H.L. Chan, S.W. Tsang, N.W. Leung, C.H. Tse, Y. Hui, and J.S. Tam Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection Am J Gastroenterol 97 2002 1211 1215 (Pubitemid 34478124)
21. C.J. Liu, D.S. Chen, and P.J. Chen Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT J Clin Virol 36 Suppl. 1 2006 S33 S44
22. S.M. Alavian, B. Hajariazdeh, M. Ahmadzad Asl, A. Kabir, and K. Bagheri Lankarani Hepatitis B virus infection in Iran: a systematic review Hepat Mon 8 2008 281 294
23. E. Hajiani, S. Hashemi, and A. Masjedizadeh Seroepidemiology of hepatitis B virus infection in Khuzestan Province, Southwest of Iran Hepat Mon 9 2009 34 38
24. Z. Nokhodian, N. Kassaian, B. Ataei, A.A. Javadi, P. Shoaei, and Z. Farajzadegan Hepatitis B markers in Isfahan, Central Iran: a population-based study Hepat Mon 9 2009 12 16
25. S.M. Alavian Ministry of Health in Iran is serious about controlling hepatitis B Hepat Mon 7 2007 3 5
26. S.M. Alavian, M.M. Gooya, B. Hajarizadeh, A.R. Esteghamati, A.M. Moeinzadeh, and M. Haghazali Mass vaccination campaign against hepatitis B in adolescents in Iran: estimating coverage using administrative data Hepat Mon 9 2009 189 195
27. A. Moradi, B. Khodabakhshi, G. Roshandel, K. Kalavi, S. Besharat, and S. Semnani Response to the hepatitis B virus vaccine in Iranian infants Hepat Mon 9 2009 229 231
28. S.M. Hosseini, R. Ranjbar, H. Abolghasemi, and M. Turkaman Evaluation of the level of HBV antibody titer after HBV vaccination among children in Tehran, Iran Hepat Mon 9 2009 150 153
29. A. Kabir, S.M. Alavian, N. Ahanchi, and R. Malekzadeh Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg-positive mothers in comparison with vaccine alone Hepatol Res 36 2006 265 271 (Pubitemid 44752674)
30. S.A. Hashemi, M. Moghadami, K.B. Lankarani, A. Alborzi, and A. Mahboudi The efficacy of hepatitis B vaccination among school age children in Southern Iran Iran Red Cres Med J 12 2010 45 48
31. P. Adibi, R. Ghassemian, S.M. Alavian, M. Ranjbar, A.H. Mohammadalizadeh, and F. Nematizadeh Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers Saudi Med J 25 2004 1414 1418 (Pubitemid 39429595)
32. Y. Yahyapour, M. Karimi, O. Hashemzadeh, S.M. Jazayeri, Z. Saadatmand, and M. Mahmoodi Seromarkers of hepatitis B virus in children of HBs Ag positive mothers J Gorgan Univ Med Sci 11 2009 43 48 [in Persian]
33. S. Gunther, B.C. Li, S. Miska, D.H. Kruger, H. Meisel, and H. Will A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients J Virol 69 1995 5437 5444
34. M. Jazayeri, A.A. Basuni, N. Sran, R. Gish, G. Cooksley, and S. Locarnini HBV core sequence. definition of genotype-specific variability and correlation with geographical origin J Viral Hepat 11 2004 488 501 (Pubitemid 39486612)
35. Z. Goodarzi, R. Malekzadeh, G. Montazeri, S.M. Alavian, M. Qurbanalizadgan, and M. Daram Phylogenetic analysis of HBV based on PreS region in Iranian hepatocellular carcinoma patients Hepat Mon 7 2007 201 205
36. X.H. Liu, J. Lin, S.H. Zhang, S.M. Zhang, M.A. Feitelson, and H.J. Gao COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma World J Gastroenterol 14 2008 1346 1352 (Pubitemid 351425212)
37. I. Chemin, and C. Trepo Clinical impact of occult HBV infections J Clin Virol 34 Suppl. 1 2005 S15 S21
38. G. Raimondo, T. Pollicino, I. Cacciola, and G. Squadrito Occult hepatitis B virus infection J Hepatol 46 2007 160 170 (Pubitemid 44827430)
39. S.C. Mu, Y.M. Lin, G.M. Jow, and B.F. Chen Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan J Hepatol 50 2009 264 272
40. W.N. Chen, and C.J. Oon Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg J Clin Microbiol 38 2000 2793 2794
41. V. Chaudhuri, R. Tayal, B. Nayak, S.K. Acharya, and S.K. Panda Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter Gastroenterology 127 2004 1356 1371 (Pubitemid 39457762)
42. T. Pollicino, G. Raffa, L. Costantino, A. Lisa, C. Campello, and G. Squadrito Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma Hepatology 45 2007 277 285 (Pubitemid 46374584)
43. M. Cabrerizo, J. Bartolome, C. Caramelo, G. Barril, and V. Carreno Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases Hepatology 32 2000 116 123 (Pubitemid 30432375)
44. B. Weber, W. Melchior, R. Gehrke, H.W. Doerr, A. Berger, and H. Rabenau Hepatitis B virus markers in anti-HBc only positive individuals J Med Virol 64 2001 312 319 (Pubitemid 32565127)
45. M. El Chaar, D. Candotti, R.A. Crowther, and J.P. Allain Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection Hepatology 52 2010 1600 1610
46. A. Banerjee, P.K. Chandra, S. Datta, A. Biswas, P. Bhattacharya, and S. Chakraborty Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India J Clin Virol 40 2007 312 317 (Pubitemid 350151995)
47. E. Brojer, P. Grabarczyk, G. Liszewski, M. Mikulska, J.P. Allain, and M. Letowska Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT Hepatology 44 2006 1666 1674 (Pubitemid 44953671)
48. T. Pollicino, L. Belloni, G. Raffa, N. Pediconi, G. Squadrito, and G. Raimondo Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones Gastroenterology 130 2006 823 837 (Pubitemid 43374531)
49. J. Sheldon, B. Rodes, F. Zoulim, A. Bartholomeusz, and V. Soriano Mutations affecting the replication capacity of the hepatitis B virus J Viral Hepat 13 2006 427 434
50. M. Nassal The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly J Virol 66 1992 4107 4116
51. M. Kann, and W.H. Gerlich Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus J Virol 68 1994 7993 8000 (Pubitemid 24362687)
52. Y. Chen, W.S. Robinson, and P.L. Marion Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis J Virol 68 1994 5232 5238 (Pubitemid 24226592)
53. E. Mizukoshi, J. Sidney, B. Livingston, M. Ghany, J.H. Hoofnagle, and A. Sette Cellular immune responses to the hepatitis B virus polymerase J Immunol 173 2004 5863 5871 (Pubitemid 39392177)
54. F.X. Ding, F. Wang, Y.M. Lu, K. Li, K.H. Wang, and X.W. He Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma Hepatology 49 2009 1492 1502
55. R. Fukuda, N. Ishimura, M. Niigaki, S. Hamamoto, S. Satoh, and S. Tanaka Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance J Med Virol 58 1999 201 207 (Pubitemid 29278020)
56. W. Jilg, E. Sieger, R. Zachoval, and H. Schatzl Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus J Hepatol 23 1995 14 20
57. J.A. Waters, M. Kennedy, P. Voet, P. Hauser, J. Petre, and W. Carman Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant J Clin Invest 90 1992 2543 2547 (Pubitemid 23010076)